Ligand Pharmaceuticals stock hits 52-week high at $172.49
PositiveFinancial Markets

Ligand Pharmaceuticals has reached a significant milestone as its stock hits a 52-week high of $172.49. This achievement reflects strong investor confidence and positive market trends for the company, which is crucial for its growth and future projects. Such a high stock price can attract more investors and enhance the company's reputation in the competitive pharmaceutical industry.
— Curated by the World Pulse Now AI Editorial System